Why people use TB-500 for rotator cuff repair
Shoulder injury, considering TB-500 over or with BPC-157. The honest answer: there is moderate animal data and very little in humans. Cell-migration mechanism complementary to BPC-157's blood-vessel growth.
This page covers what's known, what's not, and what the editorial take is for normal humans considering TB-500 for rotator cuff repair.
What the evidence says
Evidence tier: Moderate animal evidence. Reasonable animal evidence; mechanism plausible but human translation is unproven.
- Cell-migration mechanism complementary to BPC-157's blood-vessel growth.
- Often paired with BPC-157 in 'Wolverine blend' protocols.
- Animal evidence for soft-tissue healing across decades of veterinary use.
Protocol notes
2-2.5mg subcutaneous twice weekly for 4-6 weeks. Often stacked with BPC-157.
Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.
What to skip
- Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
- Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
- Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.
Where to go next
- Full TB-500 directory entry - status, sourcing, studies, what to skip
- What are peptides - if you skipped the foundation
- How peptides actually work - mechanism in plain English
- The Tier List - which ones to take seriously
- Subscribe to the dispatch